CIK 0001642380
- Non-accelerated filer
- Smaller reporting company
Insight Molecular Diagnostics Inc.
Sign in to watch- Ticker
- IMDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 271041563
- Phone
- +1 949-409-7600
- Business address
- 2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
- Former names
- OncoCyte Corp, Oncocyte Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 23 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-26 | James Andrea S. Chief Financial Officer | Exercise or conversion | +28,302 | 217,358 | ||
| 2026-03-26 | James Andrea S. Chief Financial Officer | Shares withheld for taxes | −11,298 | $4.11 | $46K | 206,060 |
| 2026-03-26 | James Andrea S. Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −28,302 | 84,905 | ||
| 2025-10-31 | James Andrea S. Chief Financial Officer | Exercise or conversion | +50,000 | 201,231 | ||
| 2025-10-31 | James Andrea S. Chief Financial Officer | Shares withheld for taxes | −12,175 | $6.01 | $73K | 189,056 |
| 2025-10-31 | James Andrea S. Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −50,000 | 50,000 | ||
| 2025-10-31 | James Andrea S. Chief Financial Officer | Exercise or conversion | +50,000 | 201,231 | ||
| 2025-10-31 | James Andrea S. Chief Financial Officer | Returned to the company · Restricted Stock Units | +50,000 | 50,000 | ||
| 2025-09-28 | James Andrea S. Chief Financial Officer | Grant or award · Option to Purchase Common Stock | +235,000 | 235,000 | ||
| 2025-03-26 | James Andrea S. Chief Financial Officer | Grant or award · Restricted Stock Units | +113,207 | 113,207 | ||
| 2025-02-07 | James Andrea S. Chief Financial Officer | Purchase | +97,561 | $2.05 | $200K | 151,231 |
| 2024-12-05 | James Andrea S. Chief Financial Officer | Purchase | +20,000 | $2.29 | $46K | 53,670 |
| 2024-10-11 | James Andrea S. Chief Financial Officer | Grant or award · Options to Purchase Common Stock | +200,000 | 200,000 | ||
| 2024-10-11 | James Andrea S. Chief Financial Officer | Grant or award · Restricted Stock Units | +100,000 | 100,000 | ||
| 2024-10-02 | James Andrea S. Chief Financial Officer | Purchase | +33,670 | $2.97 | $100K | 33,670 |
| 2024-06-20 | James Andrea S. Chief Financial Officer | Grant or award · Option to Purchase Common Stock | +200,000 | 200,000 | ||
| 2024-06-20 | James Andrea S. Chief Financial Officer | Grant or award · Restricted Stock Units | +100,000 | 300,000 |
Page 1 of 1 · 17 trades